Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.64 |
| ▸ | CA1 | P00915 | 4/20 | 0.64 |
| ▸ | CA2 | P00918 | 4/20 | 0.64 |
| ▸ | CA6 | P23280 | 4/20 | 0.64 |
| ▸ | CA9 | Q16790 | 4/20 | 0.64 |
| ▸ | CA4 | P22748 | 3/20 | 0.64 |
| ▸ | CA7 | P43166 | 3/20 | 0.64 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | TPMT | P51580 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | KDM5A | P29375 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30329647 | 1.00 | CA12 (0.64) | CA12CA1CA2CA6CA9 | |
| SCHEMBL28129734 | 0.84 | EYA3 (0.53) | CA12CA1CA2CA6CA9 | |
| SCHEMBL11430601 | 0.83 | CPT1B (0.50) | CA12CA1CA2CA6CA9 | |
| SCHEMBL351139 | 0.82 | CA12 (0.64) | CA12CA1CA2CA6CA9 | |
| SCHEMBL30574437 | 0.82 | CA12 (0.64) | CA12CA1CA2CA6CA9 | |
| SCHEMBL2723610 | 0.81 | TPMT (0.58) | CA12CA1CA2CA6CA9 | |
| SCHEMBL29364242 | 0.81 | TPMT (0.58) | CA12CA1CA2CA6CA9 | |
| SCHEMBL10594355 | 0.80 | LCK (0.53) | CA12CA1CA2CA6CA9 | |
| SCHEMBL10962857 | 0.80 | LCK (0.53) | CA12CA1CA2CA6CA9 | |
| SCHEMBL16675516 | 0.80 | ESR1 (0.47) | CA12CA1CA2CA6CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118549570-A | Detection method of 13 disinfection byproducts in sediment | 上海市环境科学研究院 | 2024-08-27 | — | — | CN | claimed |
| CN-118465139-B | Rapid screening and identifying method for phosphorus disinfection byproducts based on mass spectrum fragments | 同济大学 | 2024-10-18 | — | — | CN | disclosed |
| CN-115677616-B | Macrocyclic sulfonamide compound, preparation method and medical application thereof | 中国药科大学 | 2024-10-18 | — | — | CN | disclosed |
| CN-118549570-A | Detection method of 13 disinfection byproducts in sediment | 上海市环境科学研究院 | 2024-08-27 | — | — | CN | disclosed |
| CN-118465139-A | Rapid screening and identifying method for phosphorus disinfection byproducts based on mass spectrum fragments | 同济大学 | 2024-08-09 | — | — | CN | disclosed |
| US-20240219830-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240219830-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-06-27 | — | — | US | disclosed |
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-06-27 | — | — | US | disclosed |
| EP-3953360-B1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) | HOFFMANN LA ROCHE (CH) | 2024-02-28 | — | — | EP | disclosed |
| EP-0287909-A1 | Amyloidosis and Alzheimer's disease diagnostic assay and reagents therefor | SALUTAR, INC. (US) | 1988-10-26 | — | — | EP | disclosed |
| US-4778897-A | 6H-dibenz[b,e][1,4]oxathiepin compounds | MERCK & CO., INC. (US) | 1988-10-18 | — | — | US | disclosed |
| EP-0105692-B1 | 6-H-DIBENZ(B,E)(1,4)OXATHIEPIN DERIVATIVES AND THEIR PREPARATION | MERCK FROSST CANADA INC. (CA) | 1988-06-22 | — | — | EP | disclosed |
| US-4699917-A | Anti-asthmatic tetrazolyl 6H-dibenz-[B,E]-[1,4]-oxathiepin derivatives, compositions, and method of use therefor | MERCK & CO., INC. (US) | 1987-10-13 | — | — | US | disclosed |
| US-4663307-A | Anti-allergic and anti-thromboembolic 6H-dibenz-[b,e][1,4]-oxathiepin derivatives, compositions, and method of use therefor | MERCK FROSST CANADA, INC. (CA) | 1987-05-05 | — | — | US | disclosed |
| US-4582842-A | Anti-asthmatic 6H-dibenz-[b,e] [1,4]oxathiepin derivatives, compositions, and method of use therefor | MERCK & CO., INC. (US) | 1986-04-15 | — | — | US | disclosed |
| EP-0157963-A1 | 6H-dibenz (b,e)(1,4)oxathiepin compounds | MERCK & CO. INC. (US) | 1985-10-16 | — | — | EP | disclosed |
| EP-0140784-A2 | Prostaglandin antagonists | MERCK FROSST CANADA INC. (CA) | 1985-05-08 | — | — | EP | disclosed |
| US-4472586-A | 6H-Dibenz[b,e][1,4]oxathiepin derivatives | MERCK FROSST CANADA, INC. (CA) | 1984-09-18 | — | — | US | disclosed |
| EP-0105692-A1 | 6-H-dibenz(b,e)(1,4)oxathiepin derivatives and their preparation | MERCK FROSST CANADA INC. (CA) | 1984-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SCO2, CBR1, OXGR1 | CA12 224/4885CA1 113/4885CA2 87/4885 |
| US-20240219830-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | H1-0, HCN3, RER1 | CA12 465/4885CA1 98/4885CA2 26/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.